Lupin receives tentative approval from USFDA for Valbenazine capsules
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
The audit is a pre-approval inspection for three products filed from the facility
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10 mg market achieved annual sales of approximately US $26.9 million
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Marksans' OTC Famotidine Tablets USP are acid reducers
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Subscribe To Our Newsletter & Stay Updated